Vascular Web Logo

SVS  SVS Foundation

 Mentored Patient-Oriented Research Career Development Award (K23)

Annual Application Deadlines: February 12, June 12, October 12

The SVS® Foundation, (US) National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), and Department of Health and Human Services (DHHS) provide supplemental funding to an individual who receives an NHLBI Mentored Patient-Oriented Research Career Development Award (K23) directed at vascular surgeon scientists in the early stages of their research careers.


The SVS Foundation offers this award jointly with the NHLBI as a means to facilitate the research career development of individuals pursuing a career in vascular research. This award provides financial support over and above that offered by the NHLBI K23 mechanism.

The purpose of the Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented research. This mechanism provides support for three to five years of supervised study and research for clinically trained professionals who have the potential to develop into productive, clinical investigators focusing on patient-oriented research. Applicants must justify the need for a period of mentored research experience and provide a convincing case that the proposed period of support and career development plan will substantially enhance their careers as independent investigators in patient-oriented research.

Awards in response to this program announcement are for a total project period of three, four, or five years and are not renewable. Planning, direction, and execution of the proposed career development program and research project are the responsibility of the applicant and his or her mentor(s). Grants are not transferable from one principal investigator to another.

Eligibility Requirements

The candidate must have a MD degree or equivalent, must have completed postgraduate clinical training in vascular surgery, must identify a mentor with extensive research experience, and must be willing to spend a minimum of 75 percent of full time professional effort conducting research career development and clinical research.

Salary Support

The SVS Foundation and NHLBI will each provide salary and fringe benefits for the K23 recipient. NHLBI awards up to US$75,000 up to five years, and SVS Foundation provides US$50,000 up to three years. No indirect costs are paid to the institution.

Awards in response to this program announcement use the K23 mechanism. Applications should conform to the guidelines published for the NIH Mentored Patient-Oriented Research Career Development Award (K23). Applications must be submitted electronically using the SF424 Research and Related (R and R) forms and the SF424 (R and R) Application Guide.

Application dates are available online.

To be considered for SVS Foundation supplemental funding, you must submit your application to NHLBI and SVS Foundation at the same time. If you are selected to receive the supplemental award, SVS Foundation will contribute US$50,000 per year in addition to whatever is awarded by the NHLBI under the K23 provisions.

To identify the application as a response to this program announcement:

    1. Submit your complete K23 application as required by the NHLBI.
    2. Submit an electronic copy of your complete application to: SVS Foundation Research and Education Committee at
    3. Submit an electronic copy to: Jane D. Scott, ScD, MSN, FAHA, Director, Office of Research Training and Career Development, Division of Cardiovascular Disease, National Heart, Blood, and Lung Institute, NIH, Rockledge II, 8138, 6701 Rockledge Drive, Bethesda, MD 20892, USA.

Review Considerations

Applications are reviewed for completeness by the Center for Scientific Review and for responsiveness to this program announcement by SVS Foundation and NHLBI. Applications that are complete and responsive to the program announcement are evaluated for scientific and technical merit by an appropriate peer review group convened at NHLBI in accordance with the standard NIH peer review procedures. Representatives of the SVS Foundation Research and Education Committee participate in the NIH peer review group. As part of the initial merit review, all applications receive a written critique and undergo a process in which only those applications deemed to have the highest scientific merit, generally the top half of applications under review, are discussed, assigned a priority score, and receive a second level review by the appropriate advisory council or board. The applications also receive a secondary review by the SVS Foundation Research and Education Committee.

Award Process

Following a submission to both NHLBI and SVS Foundation, continue to inform the SVS Foundation Research and Education Committee of activity related to the K23 application including resubmission and funding. In the early months of each year, the SVS Foundation Research and Education Committee reviews applications that have received NHLBI/NIH funding. Persons selected to receive the SVS Foundation supplemental award, will receive it at the Vascular Annual Meeting® in June.


For questions regarding eligibility requirements and the K23 application process:

Jane D. Scott, ScD, MSN, FAHA
Director, Office of Research Training and Career Development
Division of Cardiovascular Disease
National Heart, Blood, and Lung Institute, NIH
Rockledge II, 8138
6701 Rockledge Drive
Bethesda, MD 20892
Telephone: 301-435-0535
Fax: 301-480-7404

For questions, email or telephone 800-258-7188.

Updated April 2011

Contact Us

Society for Vascular Surgery
633 North Saint Clair Street, 22nd Floor | Chicago, IL 60611
Phone: 312-334-2300 | 800-258-7188
Fax: 312-334-2320

Follow Us


VascularWeb® is the prime source for all vascular health and disease information, and is presented by the Society for Vascular Surgery®. Its members are vascular surgeons, specialists, and vascular health professionals who are specialty-trained in all treatments for vascular disease including medical management, non-invasive procedures, and surgery.